Rebecca Brachman: Could a Drug Prevent Depression and PTSD? (Transcript)

Here is the full transcript of neuroscientist Rebecca Brachman’s TED Talk: Could a Drug Prevent Depression and PTSD?

Listen to the MP3 Audio:  Could a drug prevent depression and PTSD by Rebecca Brachman

TRANSCRIPT: 

This is a tuberculosis ward, and at the time this picture was taken in the late 1800s, one in seven of all people died from tuberculosis. We had no idea what was causing this disease.

The hypothesis was actually it was your constitution that made you susceptible. And it was a highly romanticized disease. It was also called consumption, and it was the disorder of poets and artists and intellectuals. And some people actually thought it gave you heightened sensitivity and conferred creative genius.

By the 1950s, we instead knew that tuberculosis was caused by a highly contagious bacterial infection, which is slightly less romantic. But that had the upside of us being able to maybe develop drugs to treat it.

So doctors had discovered a new drug, iproniazid, that they were optimistic might cure tuberculosis, and they gave it to patients, and patients were elated. They were more social, more energetic. One medical report actually says they were “dancing in the halls”. And unfortunately, this was not necessarily because they were getting better. A lot of them were still dying.

Another medical report describes them as being “inappropriately happy”. And that is how the first antidepressant was discovered. So accidental discovery is not uncommon in science, but it requires more than just a happy accident. You have to be able to recognize it for discovery to occur.

As a neuroscientist, I’m going to talk to you a little bit about my firsthand experience with whatever you want to call the opposite of dumb luck — let’s call it smart luck.

But first, a bit more background. Thankfully, since the 1950s, we’ve developed some other drugs and we can actually now cure tuberculosis. And at least in the United States, though not necessarily in other countries, we have closed our sanitoriums and probably most of you are not too worried about TB.

ALSO READ:   My Courtroom Battle With a Holocaust Denier: Dr. Deborah E. Lipstadt at TEDxSkoll (Transcript)

But a lot of what was true in the early 1900s about infectious disease, we can say now about psychiatric disorders. We are in the middle of an epidemic of mood disorders like depression and post-traumatic stress disorder, or PTSD.

One in four of all adults in the United States suffers from mental illness, which means that if you haven’t experienced it personally or someone in your family hasn’t, it’s still very likely that someone you know has, though they may not talk about it.

Depression has actually now surpassed HIV/AIDS, malaria, diabetes and war as the leading cause of disability worldwide. And also, like tuberculosis in the 1950s, we don’t know what causes it. Once it’s developed, it’s chronic, lasts a lifetime, and there are no known cures.

The second antidepressant we discovered, also by accident, in the 1950s, from an antihistamine that was making people manic, imipramine. And in both the case of the tuberculosis ward and the antihistamine, someone had to be able to recognize that a drug that was designed to do one thing — treat tuberculosis or suppress allergies — could be used to do something very different — treat depression.

And this sort of repurposing is actually quite challenging. When doctors first saw this mood-enhancing effect of iproniazid, they didn’t really recognize what they saw. They were so used to thinking about it from the framework of being a tuberculosis drug that they actually just listed it as a side effect, an adverse side effect. As you can see here, a lot of these patients in 1954 are experiencing severe euphoria.

And they were worried that this might somehow interfere with their recovering from tuberculosis. So they recommended that iproniazid only be used in cases of extreme TB and in patients that were highly emotionally stable, which is of course the exact opposite of how we use it as an antidepressant. They were so used to looking at it from the perspective of this one disease, they could not see the larger implications for another disease.

ALSO READ:   Why Some People Find Exercise Harder Than Others: Emily Balcetis at TEDxNewYork (Transcript)

And to be fair, it’s not entirely their fault. Functional fixedness is a bias that affects all of us. It’s a tendency to only be able to think of an object in terms of its traditional use or function. And mental set is another thing. Right? That’s sort of this preconceived framework with which we approach problems.

And that actually makes repurposing pretty hard for all of us, which is, I guess, why they gave a TV show to the guy who was, like, really great at repurposing. So the effects in both the case of iproniazid and imipramine, they were so strong — there was mania, or people dancing in the halls. It’s actually not that surprising they were caught.

But it does make you wonder what else we’ve missed. So iproniazid and imipramine, they’re more than just a case study in repurposing. They have two other things in common that are really important.

One, they have terrible side effects. That includes liver toxicity, weight gain of over 50 pounds, suicidality. And two, they both increase levels of serotonin, which is a chemical signal in the brain, or a neurotransmitter. And those two things together, right, one or the two, may not have been that important, but the two together meant that we had to develop safer drugs, and that serotonin seemed like a pretty good place to start.

Pages: First |1 | 2 | 3 | ... | Next → | Last | Single Page View

Scroll to Top